Anti-TA-MUC1 bispecific antibody(Glycotope)

N/A

Report date: 2026/03/19 17:01:24

Base Information

Drug NameAnti-TA-MUC1 bispecific antibody(Glycotope)

Drug Alias NameTAMUC1 X CD3

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyCell and gene therapy > Cell therapy > Immune system cell therapyBiologics > T cell engagers

Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsMucin-1 modulators

TargetsT cell surface glycoprotein CD3Mucin-1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGlycotope Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesGlycotope Gmbh

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A